Compound Detail
CHEMBL5687009
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5687009 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NZRHNPOANBPCFM-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
454.4
MW (Da)
6.67
ALogP
4
HBA
2
HBD
71.8
PSA (Ų)
0.36
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 6.85 | 6.5 | 140.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase ABL1 | IC50 | = | 140.0 | nM | 6.85 | Inhibition of human N-terminal his tagged native ABL1 (229 to 499 residues) expr... | 21481795 |
| Tyrosine-protein kinase ABL1 | IC50 | = | 711.0 | nM | 6.15 | Inhibition of human ABL1 T315I mutant (229 to 499 residues) using ABLtide as sub... | 21481795 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21481795 | 10.1016/j.ccr.2011.03.003 | Tyrosine-protein kinase ABL1 | 2 |
Data from ChEMBL 36 via Core Engine